DexCom Beats Most Of Investors' Diabetes Device Sales Suit
A California judge has trimmed a proposed class action from shareholders of glucose monitor manufacturer DexCom Inc. who allege they were damaged by the company's misrepresentations regarding its ability to keep...To view the full article, register now.
Already a subscriber? Click here to view full article